Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism α7 receptor modulators(Neuronal acetylcholine receptor protein alpha-7 subunit modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H14ClFN4OS |
InChIKeyHLGMORDKLMTTGN-UHFFFAOYSA-N |
CAS Registry2055045-42-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | CN | 17 Oct 2018 | |
Schizophrenia | Preclinical | CN | 17 Oct 2018 |